Erratum: Trophoblast class I major histocompatibility complex (MHC)4 products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11 (Journal of Experimental Medicine (August 3, 1998) 188:3 (497-503))
Publication
, Journal Article
Schust, DJ; Tortorella, D; Seebach, J; Phan, C; Bacik, I; Bennink, JR; Yewdell, JW; Ploegh, HL
Published in: Journal of Experimental Medicine
July 5, 1999
Duke Scholars
Published In
Journal of Experimental Medicine
ISSN
0022-1007
Publication Date
July 5, 1999
Volume
190
Issue
1
Start / End Page
151
Related Subject Headings
- Immunology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Schust, D. J., Tortorella, D., Seebach, J., Phan, C., Bacik, I., Bennink, J. R., … Ploegh, H. L. (1999). Erratum: Trophoblast class I major histocompatibility complex (MHC)4 products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11 (Journal of Experimental Medicine (August 3, 1998) 188:3 (497-503)). Journal of Experimental Medicine, 190(1), 151.
Schust, D. J., D. Tortorella, J. Seebach, C. Phan, I. Bacik, J. R. Bennink, J. W. Yewdell, and H. L. Ploegh. “Erratum: Trophoblast class I major histocompatibility complex (MHC)4 products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11 (Journal of Experimental Medicine (August 3, 1998) 188:3 (497-503)).” Journal of Experimental Medicine 190, no. 1 (July 5, 1999): 151.
Schust DJ, Tortorella D, Seebach J, Phan C, Bacik I, Bennink JR, et al. Erratum: Trophoblast class I major histocompatibility complex (MHC)4 products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11 (Journal of Experimental Medicine (August 3, 1998) 188:3 (497-503)). Journal of Experimental Medicine. 1999 Jul 5;190(1):151.
Schust, D. J., et al. “Erratum: Trophoblast class I major histocompatibility complex (MHC)4 products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11 (Journal of Experimental Medicine (August 3, 1998) 188:3 (497-503)).” Journal of Experimental Medicine, vol. 190, no. 1, July 1999, p. 151.
Schust DJ, Tortorella D, Seebach J, Phan C, Bacik I, Bennink JR, Yewdell JW, Ploegh HL. Erratum: Trophoblast class I major histocompatibility complex (MHC)4 products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11 (Journal of Experimental Medicine (August 3, 1998) 188:3 (497-503)). Journal of Experimental Medicine. 1999 Jul 5;190(1):151.
Published In
Journal of Experimental Medicine
ISSN
0022-1007
Publication Date
July 5, 1999
Volume
190
Issue
1
Start / End Page
151
Related Subject Headings
- Immunology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences